Skip to main content
Clinical Trials/NCT02569671
NCT02569671
Active, not recruiting
Not Applicable

Immediate Placement of the Straumann® Bone Level Tapered Implant With Early Loading in Single Tooth Gaps in the Maxilla and Mandible Compared to Delayed Placement

Institut Straumann AG3 sites in 1 country53 target enrollmentMarch 1, 2016
ConditionsTooth Loss

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tooth Loss
Sponsor
Institut Straumann AG
Enrollment
53
Locations
3
Primary Endpoint
Mean Crestal Bone Level Change
Status
Active, not recruiting
Last Updated
9 months ago

Overview

Brief Summary

The aim of this randomized, controlled, multi-center study is to assess the clinical and radiographic outcomes of using a Straumann® Bone Level Tapered implant for immediate implantation following extraction of a tooth in the pre-molar and anterior region of the maxilla and mandible (test) compared to the outcomes of placing this implant in healed sites (control).

Detailed Description

The primary objective is to demonstrate that the change in mean peri-implant marginal bone level changes (mesial and distal) from loading to 12 months post-loading of the test treatment will not be worse than the control treatments. The secondary objectives of the study are to assess differences in clinical and radiographic outcomes between the test and control treatments at 12 months post-loading by looking at implant success and survival, buccal bone dimensional changes, implant stability, soft tissue changes, subject satisfaction, and adverse events. An additional objective is to assess long-term differences in clinical and radiographic outcomes, as measured in the primary and secondary objectives, over the span of two, three, four, and five years.

Registry
clinicaltrials.gov
Start Date
March 1, 2016
End Date
September 1, 2025
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects must have voluntarily signed the informed consent form before any study related procedures
  • Subjects must be males or females who are a minimum of 18 years of age
  • Subjects who are in need of a single tooth extraction in the pre-molar or anterior region of the maxilla or mandible (ADA tooth positions 4-13 and 20-29) and replacement with a dental implant.
  • Implants must be placed either immediately in an extraction socket or placed in a healed site (greater than 4 months healing) which has not been previously grafted.
  • Planned site for implant must have a natural tooth both mesially and distally in the adjacent tooth positions
  • Subjects must have opposing dentition (natural teeth, fixed or removable restorations)
  • There must be sufficient bone at the implant site to achieve primary stability
  • Subjects must be committed to the study and the required follow-up visits
  • Subjects must be in good general health as assessed by the Investigator

Exclusion Criteria

  • Subjects with a systemic disease that would preclude dental implant surgery
  • Subjects with any contraindications for oral surgical procedures
  • Subjects with mucosal diseases (e.g., erosive lichen planus) in the localized area around the study implant site
  • Subjects with a history of local irradiation therapy in the head/neck area
  • Subjects with any untreated endodontic lesions or untreated periodontal disease adjacent to the implant site
  • Subjects receiving, or having a history of receiving, intravenous or subcutaneous antiresorptive agents, such as bisphosphonates
  • Subjects with severe bruxing, parafunctional habits, or temporomandibular joint dysfunction
  • Any implant sites where there will be a buccal dehiscence greater than 3 mm or there will be a fenestration of the implant
  • Subjects with inadequate oral hygiene or who are unmotivated for adequate home care
  • Subjects who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene

Outcomes

Primary Outcomes

Mean Crestal Bone Level Change

Time Frame: Measured at implant loading (10-12 weeks after implant surgery) and 12 months post-loading

mean crestal bone level at 12 months - mean crestal bone level at implant loading (baseline) = Change in crestal bone level

Secondary Outcomes

  • Implant Success and Survival(12 months post-loading)
  • Buccal Bone Dimensional Changes(Measured at Implant loading and at screening and 12 months post-loading)
  • Implant Measure as Measured by ISQ at Implant Surgery(Implant surgery: Immediate Placement for Test Group = implant is placed at the time of tooth extraction. Delayed Placement is Control Group= implant is placed after 16-18 weeks of healing)
  • Implant Stability as Measured by ISQ at Implant Loading(Implant Loading=implant surgery + 10 weeks (+/-3 weeks))
  • Implant Stability as Measured by ISQ at Final Restoration(Final Restoration: 10 weeks post-loading (± 2 weeks))
  • Change in Soft Tissue Measurements(Soft tissue measurements were taken and compared between the test and the control group at final restoration (10 weeks post loading) and 12 months (± 1 month) post implant loading (implant loading=implant surgery + 10 weeks (+/-3 weeks)).)
  • Subject Satisfaction(12 months post-loading)
  • Number of Participants With Adverse Events and Adverse Device Effects Over 12 Months(Measured at each study visit and throughout 12 months)

Study Sites (3)

Loading locations...

Similar Trials